Cancer Reduced by Social Interaction (In Mice)

In a study of mice with cancer tumors, Professor Matthew During of Ohio State University found that mice placed in environments with three times as many other mice as they were usually around, and with more space, hiding places and toys, actually had their tumors go into spontaneous remission.

After three weeks in the new environment, only one in 20 of the cancerous mice showed no improvement. In most of the mice, tumor mass shrank 77 percent, and the size 43 percent. Apparently the key to the improvement was the new complex social interaction. More physical exercise alone, had no impact.

He said of the findings, “We’re really showing that you can’t look at a disease like cancer in isolation. For too long, physicians and other have stuck to what they know – surgery, chemo, radiotherapy. Traditionally working on the area of lifestyle and the brain has been a soft area.” Still mice obviously are not humans, and to generalize the findings of one mouse study to humans is questionable. He says, however, the results could be relevant to humans and cancer recovery.

Last year, a similar research study involving mice was published. Suzanne D. Conzen, MD said of the study, “This interdisciplinary research illustrates that the social environment, and a social animal’s response to that environment, can indeed alter the level of gene expression in a wide variety of tissues, not only the brain.”

The common sense view is that a person undergoing any serious illness effects and treatment, would want consistent social interaction and some support, if only for the practical assistance. The social interaction undoubtedly would help maintain a more typical daily routine and offer the same kind of connection people maintain normally.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap